1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis program supports the development of new imaging tools, advances imaging-based research, and funds novel and innovative imaging data analysis related to Alzheimer's and other neurodegenerative diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigators with projects focused on imaging research in Alzheimer's and other neurodegenerative diseases. Specific eligibility details can be found in the RFA. Confirm the full requirements in the official notice before applying.
The current listing shows up to $200,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Imaging Research in Alzheimer's and Other Neurodegenerative Diseases is funded by Alzheimer's Association and American Society of Neuroradiology (ASNR) Foundation. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs) is sponsored by Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) and Neuroendocrine Tumor Research Foundation (NETRF). This grant supports early-career basic or clinical scientists to conduct novel and innovative research in nuclear medicine related to neuroendocrine tumors, with the aim of generating preliminary data for further funding.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs (NCI) is sponsored by National Cancer Institute (NCI) - NIH. The NCI SBIR and STTR programs support small businesses in developing innovative cancer technologies with strong potential to improve health outcomes. This includes therapeutics, diagnostics, imaging technologies, and tools for cancer biology research.